Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Effect of Diflunisal on Familial Amyloidosis

This study has been completed.
Sponsor:
Collaborators:
Food and Drug Administration (FDA)
Information provided by (Responsible Party):
John L. Berk, Boston University
ClinicalTrials.gov Identifier:
NCT00294671
First received: February 21, 2006
Last updated: May 12, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
No publications provided by Boston University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):